SKIN SQUAMOUS CELL CARCINOMA
Clinical trials for SKIN SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SKIN SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for SKIN SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cells injected into skin tumors show promise in early trial
Disease control OngoingThis early-phase trial tests whether injecting special immune cells (natural killer cells) directly into skin cancer tumors can safely kill cancer cells. The study compares two types of donor NK cells—standard ones and ones engineered to be more potent—in 40 patients with basal o…
Matched conditions: SKIN SQUAMOUS CELL CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug combo shows promise in halting advanced skin cancer
Disease control OngoingThis study tests whether adding cetuximab to avelumab helps control advanced skin squamous cell carcinoma better than avelumab alone. About 60 adults with cancer that has spread will receive one of the two treatments. The goal is to see if the combination slows cancer growth and …
Matched conditions: SKIN SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Cancer-Fighting virus teams up with immunotherapy to tackle rare skin tumors
Disease control OngoingThis phase II trial is testing whether a combination of talimogene laherparepvec (a modified herpes virus that infects and kills cancer cells) and nivolumab (an immunotherapy drug) can shrink tumors in people with rare skin cancers or lymphomas that haven't responded to standard …
Matched conditions: SKIN SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC